JGC
ASPX

J. Goldman & Co’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

J. Goldman & Co’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-52,500
Closed -$1.35M – 347
2014
Q3 		$1.35M Buy
+52,500
New +$1.12M 0.08% 208

Other funds holding ASPX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

J. Goldman & Co's ASPX Position: Q4 2014 in Review

J. Goldman & Co sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q4 2014, closing a stake of 52,500 shares — an estimated $1.35M sold.

J. Goldman & Co first reported a position in ASPX in Q3 2014 and held it in 1 quarter. The position peaked at $1.35M in Q3 2014. 89 funds tracked by Wall St. Rank hold ASPX as of Q4 2014.

  • J. Goldman & Co reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • J. Goldman & Co sold 52,500 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q4 2014, an estimated $1.35M.
  • J. Goldman & Co first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q3 2014 and held it in 1 quarter.
  • J. Goldman & Co's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $1.35M in Q3 2014.
  • 89 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q4 2014.

Based on J. Goldman & Co's 13F filing for Q4 2014, filed 17 Feb 2015.